Alternatives to MDAlgorithms

PREDICTIX is an AI-powered decision support software for mental health professionals, aiding in the personalized treatment of mental health disorders.

Digital physical therapy and recovery platform using everyday sensors for ongoing health diagnostics.

Nanit provides smart baby monitors and sleep tracking solutions to help parents understand and improve their baby's sleep and development.

Sight Diagnostics develops rapid, accurate, and convenient diagnostic testing solutions, including a complete blood count analyzer.

Remote-controlled micro-robots for precise treatment of central nervous system disorders.

Scopio Labs transforms cell morphology analysis with fully digital platforms and diagnostic support for faster, more accurate disease detection.

MeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes.

Transforms smartphone cameras into medical devices for home urinalysis and digitized wound care.

Visby Medical develops and manufactures instrument-free, PCR-quality rapid diagnostic tests for infectious diseases at the point of care.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

Nucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis.

Belong.Life creates social and professional networks for patients and healthcare professionals to manage and navigate various diseases and patient journeys.

Sweetch is a digital therapeutics company leveraging AI and emotional intelligence for hyper-personalized patient engagement.

Clinical reasoning AI engine for scalable, high-value healthcare intake and assessment.

Firefly Neuroscience provides objective brain function assessments for mental illness using FDA-cleared Brain Network Analytics (BNA™) technology.

Developing advanced magnetic resonance imaging (MRI) technology for enhanced medical diagnostics.

Digital therapeutics company focused on chronic pain management through personalized care.

Harnessing genetic data for digital insights in rare and germline disorders.

Leveraging digital twins for real-time, individualized in-patient treatment optimization.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.